companyprofile

Actions

Middle East Healthcare Co.

4009
SAUDI GERMAN HEALTH
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 121.60
  • Open 122.80
  • High 123.60
  • Low 119.00
  • No. of Trades 2,961
  • Avg. Trade size* 180
  • Volume Traded 533,379
  • Value Traded (SAR) 65,109,230.80

Performance

SAUDI GERMAN HEALTH
-2.60 ( -2.14% )
Compare
Name Price Change %
Middle East Healthcare Co. 122.80 -2.14%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
119.00
% Change
-2.14
Volume Traded
174

Best Bid

Price 118.80
Volume 476

Best Offer

Price 119.00
Volume 6,529

52 WEEK

High
134.40
2024/02/07
Low
33.00
2023/03/08
Change**
244.93

PERFORMANCE

Start of Year
90.4
Year ago
34.5
3 Years ago
33.05

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Middle East Healthcare Co. (Saudi German Health) Announces the Completion of Issuing Sukuk Denominated in SAR.

    4009
    SAUDI GERMAN HEALTH -2.14 %
    1445/08/16     26/02/2024 09:22:02
  • Middle East Healthcare Company announces the commencement of the offer and subscription in its Sukuk denominated in SAR

    4009
    SAUDI GERMAN HEALTH -2.14 %
    1445/08/02     12/02/2024 08:07:52
  • Middle East Healthcare Company (Saudi German Health) Announces the Opening of the Saudi German Hospital Project in Alexandria at Egypt (Related Party) Under the Administrative Supervision Agreement

    4009
    SAUDI GERMAN HEALTH -2.14 %
    1445/07/27     08/02/2024 15:39:06
  • Middle East Healthcare Company (Saudi German Health) Announcement About the Press Release

    4009
    SAUDI GERMAN HEALTH -2.14 %
    1445/07/19     31/01/2024 08:09:09
  • Middle East Healthcare Company announces its intention to issue Sukuk denominated in Saudi Riyals by way of a public offering

    4009
    SAUDI GERMAN HEALTH -2.14 %
    1445/07/04     16/01/2024 08:01:03
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      29/03/2018 24/06/2018 12/07/2018 Account Transfer 2.00
      05/03/2017 08/06/2017 21/06/2017 Account Transfer 2.00
      20/04/2016 29/06/2016 28/07/2016 Account Transfer 2.00

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet
      Total Assets - - - -
      Total Liabilities - - - -
      Total Shareholders Equity (After Deducting the Minority Equity) - - - -
      Total Liabilities and Shareholders Equity - - - -
      Statement of Income
      Total Revenue (Sales/Operating) - - - -
      Net Profit (Loss) before Zakat and Tax - - - -
      Zakat and Income Tax - - - -
      Net Profit (Loss) after Zakat and Tax - - - -
      Total Comprehensive Income - - - -
      Profit (Loss) per Share - - - -
      Cash Flow
      Net Cash From Operating Activities - - - -
      Net Cash From Investing Activities - - - -
      Net Cash From Financing Activities - - - -
      Cash and Cash Equivalents, Beginning of the Period - - - -
      Cash and Cash Equivalents, End of the Period - - - -
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2023-09-30
      Total Assets
      4,986,420
      Total Liabilities
      3,428,705
      Total Shareholders Equity (After Deducting the Minority Equity)
      1,510,009
      Total Liabilities and Shareholders Equity
      4,986,420
      Statement of Income 2023-09-30
      Total Revenue (Sales/Operating)
      671,047
      Net Profit (Loss) before Zakat and Tax
      58,028
      Zakat and Income Tax
      -4,725
      Net Profit (Loss) after Zakat and Tax
      53,303
      Total Comprehensive Income
      54,125
      Profit (Loss) per Share
      0.58
      Cash Flow 2023-09-30
      Net Cash From Operating Activities
      163,891
      Net Cash From Investing Activities
      -185,141
      Net Cash From Financing Activities
      70,862
      Cash and Cash Equivalents, Beginning of the Period
      15,602
      Cash and Cash Equivalents, End of the Period
      65,214
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2023-11-05

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-03-03 صبحي عبدالجليل ابراهيم بترجي Chairman 0.9637397% 0.9637397% 0
      2024-03-03 محمد عبدالرحمن محمد موءمنه Board of Directors 0.0010876% 0.0010876% 0
      2024-03-03 محمد مصطفي محمد بن صديق Board of Directors 0.0001086% 0.0001086% 0
      2024-03-03 سلطان صبحي عبدالجليل بترجي Board of Directors 0.0010876% 0.0010876% 0
      2024-03-03 مكارم صبحي عبدالجليل بترجي Board of Directors 0.0010876% 0.0010876% 0
      2024-03-03 خالد عبدالجليل ابراهيم بترجي Board of Directors 0.0010876% 0.0010876% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Middle East Healthcare Co.
      Price 119.00
      Market Cap (SAR MN) 10,953
      P/E Ratio 61.94
      Index Name Index Level 1D Return
      Middle East Healthcare Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      Construct, manage, operate and maintenance for hospitals, clinics, centers, institutes, rehabilitation centers, physiotherapy, laboratory, X-Ray, pharmacies, purchasing of lands to construct buildings and investment for the company in medical projects

      Company History

      Middle East Healthcare Company (MEAHCO) is a closed joint stock company incorporated pursuant to the Ministerial Resolution number 2554 dated 16/03/1425H (corresponding to 05/05/2004G) and registered under commercial registration number 4030149460 dated 06/04/1425H (corresponding to 25/05/2004G) with a paid-up share capital of (SAR 590000000) five hundred and ninety million Saudi Riyals, of which (SAR 42040000) forty-two million and forty thousand Saudi Riyals were paid through cash contributions, while the remaining (SAR 547960000) five hundred and forty seven million and nine hundred and sixty thousand Saudi Riyals were paid through in kind contributions made by BAB consisting of SGH Madinah (including its land and buildings) SGH Aseer (including its land and buildings) and shares representing 80% of the share capital of BABAS (former owner and operator of SGH Riyadh) On 02/02/1435H (corresponding to 5/12/2013G) the EGA of the Company agreed to increase the Companies share capital from (SAR 590000000) five hundred ninety million Saudi Riyals to (SAR 767000000) seven hundred sixty seven million Saudi Riyals The increase of (SAR 177000000) one hundred and seventy seven million Saudi Riyals was covered through capitalization of the Shareholders account that resulted from their offering of additional in kind contributions to the Company which consisted of the following 1 SGH Jeddah 2 98% of the shares of AJ Sons 3 39.96% of NHCs share capital 4 Management Supervision Agreements for hospitals owned by third parties outside the Kingdom located in Dubai (UAE) Cairo (Egypt) and Sanaa (Yemen) 5 20% of BABAS which resulted in the Company fully owning BABAS and therefore fully owning SGH Riyadh which was later converted into a fully owned branch by the Company under commercial registration number 1010162269 dated 24/07/1421H (corresponding to 21/10/2000G) and a plot of land in the city of Dammam with a surface area of (30,000) thirty thousand m2 (Dammam Land) On 28/7/1436H (corresponding to 17/5/2015G) the EGA agreed to further increase the Companies share capital from (SAR 767000000) seven hundred and sixty-seven million Saudi Riyals to (SAR 920400000) nine hundred and twenty million four hundred thousand Saudi Riyals The increase of (SAR 153400000) one-hundred and fifty-three million four hundred thousand Saudi Riyals was covered through capitalization of the retained earnings account

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 920,400,000
      • Issued Shares 92,040,000
      • Paid Capital (SAR) 920,400,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2016-03-28

      Investment limits

      There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on the company's bylaw and the issued instructions by the related regulators and supervisory authorities.

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2004/05/05

      • Financial Year End

        31/12

      • Listing Date

        2016/03/29

      • External Auditors

        [Ernst & Young (EY)]

      • ISIN CODE

        SA141H01UKH9

      • Number of Employees

        4322

      • Chairman

        SOBHI ABDULJALEEL A. BATTRJEE
        Non - Executive

        SOBHI ABDULJALEEL A. BATTRJEE
        • BD Session Start
          2020-09-17
          Designation
          Chairman
        • BD Session End
          2023-09-16
          Classification
          Non - Executive
        • Qualification
          Master degree in Electrical Engineering University of Colorado United States of America 1973G. Bachelor degree in Electrical Engineering, University of Kansas United States of America 1972G
        Companies Membership
        • Memebrship Name
          NATIONAL HAIL CO. FOR HEALTHCARE
          Start Date
          2007-07-16
        • Memebrship Character
          Non executive
          End Date
          2018-11-06
        • Memebrship Name
          BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
          Start Date
          2015-08-11
        • Memebrship Character
          Non executive
          End Date
          2020-08-10
      • Board of Directors

        Makarem Sobhi A. Batterjee Non - Executive

        Makarem Sobhi A. Batterjee
        • BD Session Start
          2020-09-17
          Designation
          Board of Directors
        • BD Session End
          2023-09-16
          Classification
          Non - Executive
        • Qualification
          Executive MBA From London Business School
        Companies Membership
        • Memebrship Name
          NATIONAL HAIL CO. FOR HEALTHCARE
          Start Date
          2007-07-16
        • Memebrship Character
          Non executive
          End Date
          2018-11-06
        • Memebrship Name
          BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
          Start Date
          2015-08-11
        • Memebrship Character
          Non executive
          End Date
          2020-08-10

        Khalid Abduljaleel Ibrahim Batterjee Non - Executive

        Khalid Abduljaleel Ibrahim Batterjee
        • BD Session Start
          2020-09-17
          Designation
          Board of Directors
        • BD Session End
          2023-09-16
          Classification
          Non - Executive
        • Qualification
          PhD in Human Medicine University of Essen Germany 1985G. Bachelor degree in Human Medicine and Practical Training University of Vienna Austria 1978G.
        Companies Membership
        • Memebrship Name
          NATIONAL HAIL CO. FOR HEALTHCARE
          Start Date
          2007-07-16
        • Memebrship Character
          Non executive
          End Date
          2018-11-06
        • Memebrship Name
          BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
          Start Date
          2015-08-11
        • Memebrship Character
          Non executive
          End Date
          2020-08-10

        Mohammed Abdulrahman Moumena Independent

        Mohammed Abdulrahman Moumena
        • BD Session Start
          2020-09-17
          Designation
          Board of Directors
        • BD Session End
          2023-09-16
          Classification
          Independent
        • Qualification
          a degree in Marketing from King Fahad University of Petroleum
        Companies Membership
        • Memebrship Name
          company of Alkhabeer Capital
          Start Date
          2012-01-01
        • Memebrship Character
          Non Executive
          End Date
          2018-01-01

        AMR MOHAMED KHALID KHASHOGGI Independent

        AMR MOHAMED KHALID KHASHOGGI
        • BD Session Start
          2020-09-17
          Designation
          Board of Directors
        • BD Session End
          2023-09-16
          Classification
          Independent
        • Qualification
          MBA Business Administration Yale University, School of Management New Haven CT USA Year of Graduate: 1979 B.S. Business Administration Menlo College SBA Menlo Park CA USA Year of Graduate: 1977.
        Companies Membership
        • Memebrship Name
          Al Ahli Takaful Company
          Start Date
          2010-01-01
        • Memebrship Character
          Independent
          End Date
          2019-07-31

        Sultan Sobhi A. Batterjee Non - Executive

        Sultan Sobhi A. Batterjee
        • BD Session Start
          2020-09-17
          Designation
          Board of Directors
        • BD Session End
          2023-09-16
          Classification
          Non - Executive
        • Qualification
          Real Estate Executive Masters Program at HARVARD University in 2017 Regents Business School London Bachelors degree in International Finance and Accounting
        Companies Membership
        • Memebrship Name
          BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
          Start Date
          2015-08-11
        • Memebrship Character
          Non Executive
          End Date
          2020-08-10

        Mohammad Mustafa Bin Mohammad Omar Bin Siddiq Independent

        Mohammad Mustafa Bin Mohammad Omar Bin Siddiq
        • BD Session Start
          2020-09-17
          Designation
          Board of Directors
        • BD Session End
          2023-09-16
          Classification
          Independent
        • Qualification
          Bachelor degree in Public Administration - King Abdulaziz University 1400 A.H.
        Companies Membership
        • Memebrship Name
          Buruj Cooperative Insurance Company
          Start Date
          2013-01-07
        • Memebrship Character
          Out of the board
          End Date
          2022-03-08
      • Senior Executives

        AHMED MOHAMED SHEBL AHMED ELATREES CEO

        AHMED MOHAMED SHEBL AHMED ELATREES
        • BD Session Start
          2018-12-01
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO
        • Qualification
          Diploma in Hospital Management American University in Cairo Egypt 2005G. Diploma in Hospital Management Ain Shams University Egypt 2004G. Diploma in Healthcare Total Quality Management American University in Cairo Egypt 2003G. Master degree in Medicine in Thoracic and Cardiovascular Surgery AlAzhar University Egypt 2003G Bachelor degree in Medicine and Surgery Tanta University Egypt 1993G

        MADANI BAHYELDIN ABBAS HOZAIEN CFO

      MADANI BAHYELDIN ABBAS HOZAIEN
      • BD Session Start
        2019-06-30
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO
      • Qualification
        2016 MBA International Paris from Paris Dauphine University together with the University of Paris1 Pantheon Sorbonne France. 2016 Master in Economy from the University of Paris1 Pantheon Sorbonne France 2005 Diploma in Finance from the Arab Academy for Science and Technology (AAST) Cairo Egypt 1990 Diploma in Superieur de francais des Affaires de la Chamber de Commerce et d Industries de Paris 1987 B.Sc. of Commerce (Accounting) from Ain Shams University Cairo Egypt

      Investor Relations

      Contact Name:

      MUATH MOHAMMED ALZARKAN

      Company Address:

      Jeddah, Batterjee Street, Al Zahra District P.O.BOX2550 Jeddah 21461

      Contact Details:

      Telephone: 0966-12-2606000
      Fax : 00966-12-6835874
      Email : president4@sghgroup.net

      Company Website:

      www.meahco.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.